Clinical Trial Update: Microdose Study of Melphalan, Bortezomib and Dexamethasone [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial update evaluating a microdose combination of melphalan, bortezomib, and dexamethasone for multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Alkeran (melphalan)
• Decadron (Dexamethasone)
• Velcade (bortezomib)

Snippet

Sponsor: Henrik Gregersen | Conditions: Multiple Myeloma | EARLY_Phase 1 | Status: UNKNOWN